CHOSA Oncology AB Logo

CHOSA Oncology AB

CHOSA | SPGR

Overview

Corporate Details

ISIN(s):
SE0007784319
LEI:
5493002SFL9YXB0A0027
Country:
Sweden
Address:
C/O Medicon Village, C/O Medicon Village, Scheeletorget 1, 223 81 Lund
Sector:
Health Care
Industry:
Biotechnology

Description

Chosa Oncology, Danish -Swedish biotechnology company, has developed the iCIP platform, which includes a liposomal formulation of cisplatin (LiPlaCis) and the companion diagnostic (DRP) tool detecting patients who benefits the most of the cisplatin treatment. The recently achieved clinical phase 2b results mean that the Company is now gearing up the business development activities to find partners for partnership or trade deal.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
SenzaGen AB Logo SenzaGen AB Sweden SENZA
SoftOx Solutions AS Logo SoftOx Solutions AS Norway SOFTX
Spago Nanomedical AB Logo Spago Nanomedical AB Sweden SPAGO
Spermosens AB (publ) Logo Spermosens AB (publ) Sweden SPERM
Spexis AG Logo Spexis AG Switzerland SPEX
Sprint Bioscience Logo Sprint Bioscience Sweden SPRINT
Stayble Therapeutics AB Logo Stayble Therapeutics AB Sweden STABL
Stem Cells Spin Spolka Akcyjna Logo Stem Cells Spin Spolka Akcyjna Poland SCS
Strategic Partners A/S Logo Strategic Partners A/S Denmark STRAP
STRIX GROUP PLC Logo STRIX GROUP PLC Isle of Man KETL